Your session is about to expire
← Back to Search
Influenza Vaccine for Flu
Study Summary
This trial tests the effectiveness of a flu vaccine in healthy adults by measuring the response of their immune systems.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 985 Patients • NCT02290691Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a healthy adult.I am an adult capable of making my own decisions and not easily influenced.I belong to any gender, race, or ethnic group.I have difficulty making decisions due to cognitive issues.I am unable to give consent for medical procedures.I can make my own medical decisions.
- Group 1: Influenza Vaccine
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical trial accommodate individuals over the age of 50?
"This clinical trial seeks out patients within the 18-49 age range. There are, however, 43 medical studies exclusively for minors and 78 trials targeting elderly citizens."
Are researchers still recruiting participants for this experiment?
"Data from clinicaltrials.gov suggests that this trial is not recruiting at present, despite having been posted on November 1st 2022 and updated 8 days later. Nonetheless, 124 other studies are presently seeking participants to join their trials."
Is eligibility for this trial open to applicants like myself?
"This clinical study is aiming to enrol 90 individuals between 18 and 49 years of age, who are currently afflicted with flu caused by the influenza virus. This trial is open to all genders, races and minority groups – as the complications related to influenza may affect people from any background. The composition of participants should reflect a wide range of demographics for maximum efficacy in data collection. Furthermore, only those who can provide independent consent and have no existing health conditions will be considered eligible."
Share this study with friends
Copy Link
Messenger